{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"submitter":["Afrin H"],"funding":["Common Fund","Cancer Prevention and Research Institute of Texas"],"pubmed_abstract":["Cancer is a major health concern worldwide and is still in a continuous surge of seeking for effective treatments. Since the discovery of RNAi and their mechanism of action, it has shown promises in targeted therapy for various diseases including cancer. The ability of RNAi to selectively silence the carcinogenic gene makes them ideal as cancer therapeutics. Oral delivery is the ideal route of administration of drug administration because of its patients' compliance and convenience. However, orally administered RNAi, for instance, siRNA, must cross various extracellular and intracellular biological barriers before it reaches the site of action. It is very challenging and important to keep the siRNA stable until they reach to the targeted site. Harsh pH, thick mucus layer, and nuclease enzy"],"journal":["Cancer metastasis reviews"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC10040933"],"repository":["biostudies-literature"],"pubmed_title":["Oral delivery of RNAi for cancer therapy."],"pmcid":["PMC10040933"],"funding_grant_id":["PR210153","R03OD032624"],"pubmed_authors":["Afrin H","Agarwal SK","Nurunnabi M","Geetha Bai R","Kumar R","Ahmad SS"],"additional_accession":[]},"is_claimable":false,"name":"Oral delivery of RNAi for cancer therapy.","description":"Cancer is a major health concern worldwide and is still in a continuous surge of seeking for effective treatments. Since the discovery of RNAi and their mechanism of action, it has shown promises in targeted therapy for various diseases including cancer. The ability of RNAi to selectively silence the carcinogenic gene makes them ideal as cancer therapeutics. Oral delivery is the ideal route of administration of drug administration because of its patients' compliance and convenience. However, orally administered RNAi, for instance, siRNA, must cross various extracellular and intracellular biological barriers before it reaches the site of action. It is very challenging and important to keep the siRNA stable until they reach to the targeted site. Harsh pH, thick mucus layer, and nuclease enzy","dates":{"release":"2023-01-01T00:00:00Z","publication":"2023 Mar","modification":"2025-04-04T22:43:01.314Z","creation":"2024-12-03T23:02:20.774Z"},"accession":"S-EPMC10040933","cross_references":{"pubmed":["36971908"],"doi":["10.1007/s10555-023-10099-x"]}}